Retinal Consultants of Arizona

Name

Retinal Consultants of Arizona

Legal name

Retinal Consultants of Arizona

Website

https://retinalconsultantsaz.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive retinal medical services including diagnostic exams, treatments, and surgical procedures for various retinal conditions.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Retinal Consultants of Arizona provides specialized medical services for the diagnosis and management of retinal, vitreous, and macular diseases through 14 locations across Arizona. The practice delivers comprehensive retinal care including diagnostic imaging, medical management, laser treatment, and surgical procedures (vitrectomy, scleral buckle, pneumatic retinopexy) for conditions such as macular degeneration, diabetic retinopathy, retinal detachment, and macular holes. The practice also operates the Retinal Research Institute, an in-house clinical research division conducting trials since 1998 for emerging retinal therapies.

Product overview

Retinal Consultants of Arizona is Arizona's largest ophthalmology practice focused specifically on retinal care, established in 1980 and now operating 14 locations. The practice offers a comprehensive suite of retinal and vitreous services centered on a core clinical platform — diagnosis and medical/surgical management of retinal conditions including diabetic retinopathy, macular degeneration, macular holes, retinal detachment, and uveitis. The clinical offering is anchored by in-office procedures (anti-VEGF injections, laser photocoagulation), vitrectomy surgery, and emergency eye care. A distinguishing component is the Retinal Research Institute, an in-house clinical research division conducting trials since 1998 that provides patients access to experimental therapies for wet AMD, geographic atrophy, diabetic macular edema, and retinal vein occlusion. Supporting patient engagement are a NextGen Healthcare-powered patient portal, online bill pay, and online appointment scheduling. All physicians are Board Certified by the American Board of Ophthalmology with subspecialty vitreoretinal training.

Differentiator

Problem solved

Functional benefit

Brands

• Retinal Research Institute: Clinical research arm of Retinal Consultants of Arizona, conducting clinical trials for retinal conditions since 1998

Products and services

• Diabetic Retinopathy Treatment Diagnosis and treatment of diabetic retinopathy including nonproliferative and proliferative stages, utilizing eye injections, laser treatment, and vitrectomy surgery for diabetic patients with retinal complications.
• Macular Degeneration Treatment Treatment for dry and wet age-related macular degeneration (AMD), including anti-VEGF injections, AREDS2 vitamin recommendations, OCT and fluorescein angiography imaging, and Amsler grid home monitoring for elderly patients with macular degeneration.
• Diabetic Macular Edema Treatment Treatment for diabetic macular edema (DME) including intravitreal injections, laser treatments, medication, and a long-acting implant (size of a rice grain) providing up to 3 years of treatment for diabetic patients with macular swelling.
• Macular Hole Surgery Vitrectomy surgery for macular hole closure, achieving over 90% anatomic success rate. The procedure removes vitreous gel and replaces it with a temporary gas bubble for patients with macular holes affecting central vision.
• Macular Pucker (Epiretinal Membrane) Surgery Vitrectomy surgery to remove membrane tissue from the retinal surface, allowing the macula to flatten and vision to improve for patients with epiretinal membrane causing visual distortion.
• Retinal Detachment Surgery Surgical repair of retinal detachment including pneumatic retinopexy (office-based), scleral buckle surgery, and vitrectomy, with 85-90% anatomical success rate for patients with detached retinas.
• Retinal Tear Treatment Laser photocoagulation or cryopexy procedures to create a scar around retinal tears, forming a barricade to prevent retinal detachment in patients with retinal tears.
• Retinal Artery Occlusion Treatment Evaluation and monitoring of retinal artery occlusions including central and branch types, with coordination for stroke and cardiovascular risk assessment for patients with vascular retinal events.
• Retinal Vein Occlusion Treatment Treatment for central (CRVO) and branch (BRVO) retinal vein occlusions, including steroid or anti-VEGF injections (Avastin, Lucentis), laser treatment, and surgery for neovascular glaucoma.
• Uveitis Treatment Treatment for inflammation of the uvea and eye, including steroid eye drops, injections, pills, dilating drops, and chemotherapeutic immunosuppressive medications for severe cases in patients with ocular inflammation.
• Posterior Vitreous Detachment Evaluation Diagnosis and monitoring of posterior vitreous separation using dilated retinal exam and OCT imaging to detect associated retinal tears or detachments in patients presenting with new floaters or flashes.
• Floaters Treatment Evaluation of floaters resulting from vitreous opacities or vitreous hemorrhage, with dilated exam and OCT imaging to determine underlying causes in patients with new-onset visual floaters.
• Flashes Treatment Evaluation and treatment of flashes caused by vitreoretinal traction, often associated with posterior vitreous separation, retinal tears, or retinal detachment in patients with photopsia symptoms.
• Low Vision Referrals Referral-only low vision services providing patients with resources and information about low-vision specialists, optical devices, rehabilitation programs, and support services.
• Emergency Eye Care Urgent evaluation and treatment of sudden vision changes including floaters, flashes, curtain/shadow over vision, and sudden vision loss, with same-day treatment available when needed.
• Retinal Research Institute (Clinical Trials) Clinical research division of Retinal Consultants of Arizona, conducting clinical trials since 1998 for wet AMD, dry AMD (Geographic Atrophy), diabetic macular edema, and retinal vein occlusion. Described as one of the nation's largest retina-only research organizations. Provides patients with access to experimental therapies sponsored by companies including RegenexBio, Regeneron, and Genentech.
• Patient Portal Online patient portal powered by NextGen Healthcare enabling patients to access their health records, communicate with providers, and manage appointments.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature2 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• American Vision PartnerscoreStrategic or Co-development PartnerAmerican Vision Partners is the parent organization overseeing Retinal Consultants of Arizona and multiple other eye care practices. They provide administrative support, accessibility services, HIPAA compliance oversight, and non-discrimination policy governance for affiliated practices including RCA.
• RegenexBiocoreStrategic or Co-development PartnerSponsor of AAviate clinical trial for Wet AMD treatment using novel genetic therapy that codes for anti-VEGF molecule production, administered as a one-time office procedure injection under the surface of the eye.
• RegeneroncoreStrategic or Co-development PartnerSponsor of Sienna GA clinical trial for Geographic Atrophy secondary to dry macular degeneration. Study utilizes anti-complement agent via subcutaneous injection instead of eye injection, with 3-year study duration.
• GenentechcoreStrategic or Co-development PartnerSponsor of Thames clinical trial for Diabetic Macular Edema. Study uses Tie2 activator molecule in combination with Eylea or Vabysmo to promote vascular stability and prevent vascular leakage.
• Southwestern Eye CenterminorChannel Partner/ Reseller/ DistributorHost location for RCA North Scottsdale satellite office at Bell Road east of Tatum Blvd, providing local retinal care access to Scottsdale community.
• Barnet Dulaney Perkins Eye CenterminorChannel Partner/ Reseller/ DistributorHost location for RCA Flagstaff Switzer Canyon satellite office, providing retinal care access to Flagstaff community.
• M&M Eye InstituteminorChannel Partner/ Reseller/ DistributorHost location for RCA Prescott satellite office, providing expert retinal care to Prescott community patients.
• Risser-Thomas Eye ClinicminorChannel Partner/ Reseller/ DistributorHost location for RCA Payson satellite office (Risser-Thomas Eye Clinic/Risser Eye Clinic), providing retinal care access to Payson community.
• Mohave Eye CenterminorChannel Partner/ Reseller/ DistributorHost location for RCA Kingman and Bullhead City satellite offices, providing retinal care access to Mohave County communities.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Texas Retina Associates: One of the largest retina-only specialty practices in Texas, founded in the late 1970s with multiple office locations and an active clinical research program. Highly comparable to RCA as a multi-site retinal specialist practice with a research arm and regional referral network anchored by fellowship-trained vitreoretinal surgeons.
• Retina-Vitreous Associates Medical Group: Long-standing Los Angeles vitreoretinal specialty practice with multiple locations and a clinical trials program. Directly comparable to RCA as a retinal-only physician group delivering medical and surgical retinal care plus trial enrollment in a major metro market.

Broad incumbents

• EyeCare Partners: Large PE-backed (Partners Group) ophthalmology and optometry platform with hundreds of locations across the U.S. Comparable to RCA through the American Vision Partners relationship as a roll-up consolidator of ophthalmology practices, including subspecialty retina groups.
• US Eye: PE-backed (Linden Capital) multi-specialty ophthalmology platform with locations across the southeastern U.S. Comparable to AVP as a growth-and-buy platform aggregating physician-owned eye care groups, including retina service lines.
• EyeSouth Partners: PE-backed (Shore Capital) ophthalmology and optometry platform built through affiliation partnerships with medically-led practices. Comparable to AVP and RCA in structure as a doctor-services platform that provides centralized back-office support to affiliated practices.
• Bascom Palmer Eye Institute: University of Miami Health System's ophthalmology specialty hospital, consistently ranked among the top U.S. eye institutes with a major vitreoretinal service line and active clinical trial portfolio. Comparable to RCA's Retinal Research Institute as a leading site for sponsored retinal trials and complex surgical referrals.
• Wills Eye Hospital: Philadelphia-based specialty eye hospital with one of the largest U.S. retinal/vitreoretinal clinical and research programs (Mid-Atlantic Retina). Comparable to RCA as a tertiary retinal care referral destination with active sponsored clinical trials and fellowship-trained surgeons.
• Cleveland Clinic Cole Eye Institute: Academic multispecialty ophthalmology institute within Cleveland Clinic offering vitreoretinal surgery, OCT/fluorescein angiography, and clinical trials. Comparable to RCA on the retinal diagnostic and surgical imaging side within a broader academic eye care footprint.
• Mass Eye and Ear: Harvard Medical School-affiliated specialty hospital with a leading Retina Service and clinical trial program sponsored by NEI and industry. Comparable to RCA on the subspecialty retina and research dimensions as an academic center competing for trial enrollment and complex referrals.
• Emory Eye Center: Emory University academic ophthalmology department with vitreoretinal surgery, ocular imaging, and clinical trial enrollment. Comparable to RCA on the retinal subspecialty offering and trial activity within a research-driven academic setting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCIfAwUT_Bxf4NMJRY6Kzdfg
• Facebookfacebook.com/RetinalConsultantsAZ
• LinkedInlinkedin.com/company/retinal-consultants-of-arizona
• Xx.com/RCA_AZ

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retinal Consultants of Arizona